BINDING OF ANTIPSYCHOTIC-DRUGS AT ALPHA(1A)-ADRENOCEPTORS AND ALPHA(1B)-ADRENOCEPTORS - RISPERIDONE IS SELECTIVE FOR THE ALPHA(1B)-ADRENOCEPTORS

被引:53
作者
SLEIGHT, AJ [1 ]
KOEK, W [1 ]
BIGG, DCH [1 ]
机构
[1] CTR RECH PIERRE FABRE,F-81106 CASTRES,FRANCE
关键词
ALPHA(1A)-ADRENOCEPTORS; ALPHA(1B)-ADRENOCEPTORS; RISPERIDONE; ANTIPSYCHOTICS; RECEPTOR BINDING;
D O I
10.1016/0014-2999(93)90876-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The binding of the antipsychotic drugs risperidone, (+)-butaclamol, clozapine, haloperidol, spiperone, thioridazine and YM-09151-2 was studied at the subtypes of the alpha1-adrenoceptor. Saturation experiments showed that [H-3]prazosin labelled a single population of binding sites in the spleen (alpha1B) and hippocampus (alpha1A and alpha1B) (dissociation constants (K(D)): 0.26 nM and 0.14 nM respectively). Prazosin displaced the radioligand in a monophasic manner in both the spleen and hippocampus whereas 5-methyl-urapidil, phentolamine and WB 4101 displaced the radioligand in a monophasic manner in the spleen but in a biphasic manner in the, hippocampus. The affinity of these three compounds for the low affinity site in the hippocampus was similar to that observed in the spleen, suggesting that all three were selective for the alpha1A-adrenoceptor. Furthermore, the affinities for the alpha1A- and alpha1B-adrenoceptors calculated in this manner were in agreement with literature values. With the exception of risperidone, all the antipsychotic drugs tested failed to show selectivity for either of the alpha1-adrenoceptor subtypes. Risperidone was 120-fold more selective for the alpha1B-adrenoceptor with respect to the alpha1A-adrenoceptor (K(i) values: 2.3 +/- 1.2 nM and 283.6 +/- 174.1 nM respectively).
引用
收藏
页码:407 / 410
页数:4
相关论文
共 12 条
[1]   DO CENTRAL ANTIADRENERGIC ACTIONS CONTRIBUTE TO THE ATYPICAL PROPERTIES OF CLOZAPINE [J].
BALDESSARINI, RJ ;
HUSTONLYONS, D ;
CAMPBELL, A ;
MARSH, E ;
COHEN, BM .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :12-16
[2]   SUBTYPES OF ALPHA-1-ADRENERGIC AND ALPHA-2-ADRENERGIC RECEPTORS [J].
BYLUND, DB .
FASEB JOURNAL, 1992, 6 (03) :832-839
[3]   RISPERIDONE VERSUS HALOPERIDOL IN THE TREATMENT OF CHRONIC-SCHIZOPHRENIC INPATIENTS - A MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY [J].
CLAUS, A ;
BOLLEN, J ;
DECUYPER, H ;
ENEMAN, M ;
MALFROID, M ;
PEUSKENS, J ;
HEYLEN, S .
ACTA PSYCHIATRICA SCANDINAVICA, 1992, 85 (04) :295-305
[4]   INVIVO POTENCIES OF ANTIPSYCHOTIC-DRUGS IN BLOCKING ALPHA-1 NORADRENERGIC AND DOPAMINE D2 RECEPTORS - IMPLICATIONS FOR DRUG MECHANISMS OF ACTION [J].
COHEN, BM ;
LIPINSKI, JF .
LIFE SCIENCES, 1986, 39 (26) :2571-2580
[5]  
DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474
[6]  
MCPHERSON GA, 1985, COLLECTION RADIOLIGA
[7]   IDENTIFICATION OF A SINGLE ALPHA-1-ADRENOCEPTOR CORRESPONDING TO THE ALPHA-1A-SUBTYPE IN RAT SUBMAXILLARY-GLAND [J].
MICHEL, AD ;
LOURY, DN ;
WHITING, RL .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (03) :883-889
[8]  
MINNEMAN KP, 1988, PHARMACOL REV, V40, P87
[9]  
MORROW AL, 1986, MOL PHARMACOL, V29, P321
[10]   LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS [J].
MUNSON, PJ ;
RODBARD, D .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :220-239